Aerospace & Defense

This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. (Tuesday Market Close) Despite Monday’s nearly historic price swing that left the major indices closing in the positive, the S&P 500 (SPX)...

Aerojet Rocketdyne Holdings Inc (NYSE: AJRD) shares are trading lower by 18.5% at $36.72 Tuesday afternoon after the FTC sued to block the proposed merger with Lockheed Martin (NYSE: LMT). Earlier this month, Lockheed Martin and Aerojet Rocketdyne agreed with the Federal Trade Commission (FTC) to...

Aerojet Rocketdyne Holdings Inc (NYSE: AJRD) stock fell following the disclosure that it is highly likely that the Federal Trade Commission (FTC) will vote to sue to block the Lockheed Martin Corp (NYSE: LMT) transaction. Meanwhile, the FTC stated it sued to block Lockheed...

Lockheed Martin Corp (NYSE: LMT) reported fourth-quarter FY21 net sales growth of 4.1% year-over-year to $17.73 billion, beating the consensus of $17.66 billion. EPS improved to $7.47 compared to $6.38 in 4Q20, beating the consensus of $7.15. The operating profit increased by 7.3% Y...

Gainers Exterran Corporation (NYSE: EXTN) shares surged 59.7% to close at $4.79 on Monday after the company said it would merge with Enerflex to create a premier integrated global provider of energy infrastructure. ShiftPixy, Inc. (NASDAQ: PIXY) gained 38.7% to settle at $1.72 after the company...

Wells Fargo analyst Matthew Akers raised price targets for certain Aerospace & Defense companies.  The analyst upgraded Northrop Grumman Corp (NYSE: NOC) to Equal Weight from Underweight and raised the price target to $399, from $335.  Akers believes the...

Lockheed Martin Corp (NYSE: LMT), Amazon.com Inc (NASDAQ: AMZN), and Cisco Systems Inc (NASDAQ: CSCO) partnered to integrate unique human-machine interface technologies into NASA's Orion spacecraft. It would provide an opportunity to learn how future...

Morgan Stanley analyst Kristine Liwag says Aerospace stocks are not pricing in recovery as sentiment is negative, and stocks are trading at about a 27% discount to normalized 2019 levels. The analyst named TransDigm Group Inc (NYSE: TDG), her top pick in Aerospace in North...

Gainers Pasithea Therapeutics Corp. (NASDAQ: KTTA) rose 26.5% to $1.86 in pre-market trading. Pasithea recently said it expanded its footprint with second Ketamine Therapy Clinic in the UK. Osmotica Pharmaceuticals plc (NASDAQ: OSMT) rose 21.7% to $1.29 in pre-market trading. HC Wainwright &...

Lockheed Martin Corp's (NYSE: LMT) 5th Generation F-35 Lightning II is the aircraft selected by the Finnish Government from HX Fighter Program. The Finnish Air Force will receive 64 F-35A multirole stealth fighters, a weapons package, a sustainment solution tailored to Finland...

  Gainers Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) shares climbed 128.6% to close at $5.03 on Tuesday. The FDA approved expanded labeling for Cumberland Pharmaceuticals’ Caldolor, an intravenously delivered formulation of ibuprofen, to now include use in pre-operative...

KULR Technology Group Inc (NYSE: KULR) has received an initial order totaling ~$500 thousand for its passive propagation resistant battery systems from the Lockheed Martin Corp (NYSE: LMT). The order is for immediate delivery and is the starting point in the partnership as...

Gainers Longeveron Inc. (NASDAQ: LGVN) shares surged 181.2% to settle at $28.20 on Monday on continued upward momentum after the company last week announced the FDA granted Rare Pediatric Disease designation for Lomecel-B for the treatment of Hypoplastic Left Heart Syndrome. iSpecimen Inc. (NASDAQ...

CEVA Inc (NASDAQ: CEVA) reported third-quarter FY21 revenue growth of 31% year-on-year to $32.8 million, beating the consensus of $31.2 million. Segments: Licensing, non-recurring engineering (NRE), and related revenue increased 74% Y/Y to $21.6 million. Royalty revenue...

BofA analyst Ronald Epstein downgraded Lockheed Martin Corp (NYSE: LMT) to Neutral from Buy and lowered the price target to $375 (an upside of 13%), from $440, after the company reported Q3 results and gave a longer-term outlook for sales growth to decline about $1...